Clinical Trial Update: A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA) [Phase 2]

View source ↗

Summary

A Phase 2 placebo-controlled study of Volixibat in intrahepatic cholestasis of pregnancy was terminated, and the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholestasis of Pregnancy

Drugs mentioned

• Volixibat (volixibat)

Snippet

Sponsor: Mirum Pharmaceuticals, Inc. | Conditions: Intrahepatic Cholestasis of Pregnancy | Phase 2 | Status: TERMINATED | Results posted: 2024-08-06